BPC-157 Spray — Research Grade Nasal Delivery
BPC-157 Spray provides research-grade BPC-157 (Body Protective Compound-157) in a nasal spray formulation, enabling intranasal delivery for research protocols investigating CNS, neurological, or systemic effects via mucosal absorption. BPC-157 is a synthetic pentadecapeptide derived from human gastric juice with an extensive preclinical tissue repair and neuroprotection research database. This spray formulation is HPLC verified at ≥99% purity per batch.
Research Background
Intranasal delivery of BPC-157 has been explored in neurological research contexts, including traumatic brain injury models and dopaminergic system studies. Published rodent studies demonstrate that BPC-157 administered via intranasal route reaches systemic circulation and produces measurable effects on brain dopamine and serotonin metabolism — supporting its use in CNS-focused research protocols where systemic injection may confound results. Angiogenic, anti-inflammatory, and neuroprotective effects have all been documented across multiple preclinical delivery routes.
Compound Specifications
- Format: Nasal spray solution
- Purity: ≥99% (HPLC verified)
- Active compound: BPC-157
- Storage: 2–8°C refrigerated, protected from light
- Molecular Weight: 1419.5 Da
Certificate of Analysis
Third-party tested by independent ISO-certified laboratories. HPLC and MS/MS validation performed per batch. COA available on request.
For research and laboratory use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
